To compare the diagnosis of positive versus negative for mild traumatic brain injury (mTBI) using the Boston Assessment of TBI-Lifetime (BAT-L), a validated forensic clinical interview used to identify TBI in research, to the diagnosis of mTBI in the clinical polytrauma service using the Comprehensive TBI Evaluation (CTBIE). Participants: Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn Veterans who were enrolled in the Translational Research Center for TBI and Stress Disorders longitudinal cohort study and received a CTBIE at a Veterans Health Administration healthcare facility (n = 104). Main Measures: The BAT-L, CTBIE, and Neurobehavioral Symptom Inventory. Results: There was poor correspondence between the BAT-L and CTBIE mTBI diagnoses (κ = 0.283). The CTBIE showed moderate sensitivity but poor specificity relative to the BAT-L. The agreement did not improve after removing individuals who had failed symptom validity measures, as assessed by the Validity-10 scale of the Neurobehavioral Symptom Inventory. Conclusions: This lack of correspondence highlights the difficulties in diagnosing mTBI in Veterans using retrospective self-report. Future work is needed to establish a reliable and valid method for identifying military mTBI both for the care of our Veterans and for appropriate distribution of benefits. 
M ILD TRAUMATIC BRAIN INJURY (mTBI) in
Veterans returning from Operation Enduring Freedom, Operation Iraqi Freedom, and Operation New Dawn has been the focus of intense research over the last decade; however, there is still debate regarding how to best assess military concussion retrospectively. The detection of TBI, and mTBI in particular, in returning Veterans is primarily reliant on self-report of the injury months to years after the event occurred. Combat injuries often occur in stressful contexts and involve disrupted mental status and/or memory. Recall of the events is therefore vulnerable to distortion, which could lead to a misdiagnosis if based solely on self-report.
The current Department of Veterans Affairs (VA) TBI protocol, in place since 2007, mandates that all returning Veterans deployed after September 11, 2001 , receive the VA TBI Clinical Reminder Screen. 1 Individuals who screen positive on the VA TBI screen are referred for further evaluation known as the VA Comprehensive Traumatic Brain Injury Evaluation (CTBIE). 1 The CTBIE follows a specific template; however, there are no explicit guidelines offered to clinicians to help them determine whether the Veteran should receive a positive diagnosis of TBI. 2 The lack of systematic definitions and procedures leaves open the potential for inaccuracies and/or inconsistencies.
We have recently validated the Boston Assessment of TBI-Lifetime (BAT-L), 3 which could be used adjunctively to improve the validity of the CTBIE. The E52 JOURNAL OF HEAD TRAUMA REHABILITATION/SEPTEMBER-OCTOBER 2018 BAT-L TBI diagnosis is determined by the Department of Defense criteria, which include the presence of at least one of the following: altered mental status (AMS), posttraumatic amnesia (PTA), or loss of consciousness (LOC) following trauma to the head. 4 The BAT-L has demonstrated high inter-rater reliability and high correspondence with other validated TBI detection methods 3 including the VA TBI screen when administered in a research setting, but poor correspondence with the VA TBI screen when administered clinically. 5 There is an empirical base of evidence demonstrating a correlation between TBI diagnosis and blast exposure as documented by the BAT-L and objective measures of neurological and neuropsychological outcomes that are representative of TBI sequelae. 6, 7 We argue the BAT-L can serve as a "gold standard" TBI diagnostic tool to evaluate the efficacy of the CTBIE.
The present study is an extension of previous work that compared the BAT-L with the VA TBI screen. 5 This study compared the TBI diagnoses as determined by the CTBIE obtained in a VA Polytrauma Network Site to the diagnoses obtained using the BAT-L in a research setting. Reasons for discrepant diagnoses are explored, and the impact of possible symptom exaggeration is considered.
METHODS

Participants
All participants were enrolled in a longitudinal cohort study at the Translational Research Center for TBI and Stress Disorders (TRACTS) National Research Center 8 at the VA Boston Healthcare System. The present study evaluated the first 109 consecutively enrolled participants who had also received a CTBIE at a VA healthcare facility. On average participants received their CT-BIE 1.09 years before their TRACTS visit, and the exact time of the CTBIE ranged from 5.27 years before to 3.09 years after their TRACTS research visit. Five Veterans were excluded from statistical analyses because they experienced a military TBI outside of deployment (eg, stateside or during a training mission), leaving a final sample size of 104 (96 male/8 female). These 5 Veterans were excluded because the CTBIE does not account for TBIs that occur outside of deployment, whereas the BAT-L considers these military-related injuries. Thus, including these individuals would have exaggerated the discrepancy between measures.
Participants ranged in age from 21 to 61 years (mean = 31, standard deviation = 8) and on average received 13.6 years of education (mean = 13.6, standard deviation = 1.7) (see Table 1 ). The TRACTS longitudinal cohort and study procedures have been well characterized elsewhere. 8 Most Veterans received their CTBIE at a VA Boston Healthcare System hospital. Others re- ceived their CTBIE at other VA Polytrauma clinics located throughout the country, allowing for better representation of general US Veterans Health Administration procedures.
Procedures
TBI diagnoses were obtained from the BAT-L interview and the CTBIE.
BAT-L
The BAT-L employs a forensic approach to determine presence and duration of acute TBI signs at the time of each possible TBI event (eg, AMS, PTA, and LOC). There are multiple queries and probes for each event to help the interviewer develop a timeline to determine duration of these signs. Other factors that might be interpreted as alterations of consciousness (eg, chaos and confusion due to explosions, sensory changes, psychological response, and substance use) are queried. Details specific to injuries in military settings are queried such as use of protective gear, reports of medics if known, and changes to duty postinjury. Presence and duration of postconcussive symptom (PCS) post-event are recorded. Veterans are also queried about blast exposure in addition to blast TBI. The number of blasts they have been exposed to at close (0-10 m), medium (11-25 m) and far (25-100 m) distances is documented. Duration of acute signs of TBI (AMS, PTA, and LOC) is used to determine the injury severity.
CTBIE
The CTBIE does not ask for a detailed description of the injury, but it does inquire about AMS, PTA, and LOC at the time of the event. Veterans are also asked whether they are currently experiencing PCS such as headaches, dizziness, and memory impairment. This Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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is followed by a physical examination and brief assessment of current psychological functioning such as orientation, social interaction, and communication.
For a complete description of the BAT-L or the CT-BIE see Fortier et al 3 or Department of Veterans Affairs, 1 respectively.
Symptom validity measures
NSI
Participants completed the Neurobehavioral Symptom Inventory (NSI) as part of their TRACTS longitudinal assessment and as part of their CTBIE assessment. Symptom validity was coded as pass or fail on the basis of an individual's Validity-10 score, as per Vanderploeg and colleagues. 
Statistical analyses
Participants' diagnoses from the BAT-L and the CT-BIE were coded as positive or negative and compared using χ 2 in SPSS (IBM SPSS Statistics, Chicago, Illinois). Results are reported as the CTBIE diagnosis compared to the BAT-L diagnosis.
RESULTS
Correspondence between the BAT-L and the CTBIE
Overall, the BAT-L positively diagnosed 73% of Veterans in this sample with TBI compared with the CTBIE that diagnosed 68% of Veterans with TBI (see Table 2 ). To assess agreement between the BAT-L and the CT-BIE, the Cohen κ coefficient and the Kendall τ coefficient were calculated. Both measures indicated only fair consistency between the 2 assessments (Cohen κ = 0.283; Kendall τ -b = 0.285; Table 2 ). The CTBIE demonstrated diagnostic agreement with BAT-L TBI diagnosis for 73 of 104 individuals (positive TBI diagnosis agreement = 58 Veterans; negative TBI diagnosis agreement = 15 Veterans). Disagreements between the 2 instruments occurred for approximately 30% of cases.
Specifically, 18 individuals received a positive diagnosis for TBI on the basis of the BAT-L interview, but were not diagnosed with a TBI on the basis of their CTBIE (false negatives). Thirteen Veterans were not diagnosed with a TBI on the basis of the BAT-L interview, but received a positive diagnosis on the basis of the CTBIE (false positives). Using the BAT-L as the validated gold standard, these data suggest that the CTBIE has moderate sensitivity to detect TBI (76.3% sensitivity) but poor specificity (53.6%).
Description of disagreements in diagnosis
On the basis of the injury description provided in the reports for both measures, we could verify that the BAT-L and the CTBIE assessed the same index injury in 13 of 13 of the false positives and 14 of 18 false negatives. Disagreement in diagnoses fell into 4 categories: errors, inconsistent reporting, confounding factors, and TBI diagnosis made from report of PCS versus acute TBI diagnostic criteria (see Table 3 ). Many discrepancies were due to inconsistent reporting by Veterans, which may be confounding the results. Analyses with these individuals excluded found that the correspondence between the 2 measures increased, but there were still significant discrepancies between measures (χ 2 = 19.08, P < .01; Cohen κ = 0.453; Kendall τ -b = 0.453).
Symptom validity analyses:
To determine the role of symptom exaggeration in the poor correspondence between the BAT-L and the CTBIE in clinical and research visits, we conducted additional χ 2 comparisons after excluding 36 individuals who were missing or had failed the NSI symptom validity measure at either visit. Only 2 of the Veterans who had failed the symptom validity measures had discrepant research versus clinical diagnoses. The poor correspondence between the 2 measures remained (Cohen κ = 0. 234; Kendall τ -b = 0.238). One Veteran reported feeling confused after a blast woke him up in the middle of the night. This was considered AMS on the basis of the CTBIE; however, when further queried on the BAT-L, he reported that he was able to respond appropriately/perform duties as expected within seconds of awakening. His confusion was thought to be related to being awoken during a chaotic situation rather than related to acute AMS caused by a TBI PCS vs TBI diagnostic criteria 
DISCUSSION
This study found poor correspondence of TBI diagnosis between the research administration of the BAT-L and the clinically administered CTBIE. Correspondence did not improve when Veterans who failed the embedded symptom validity measure at either assessment were removed from analyses. The disagreement between the BAT-L and the CTBIE was therefore not thought to be due to issues with engagement or symptom exaggeration, indicating that the potential for monetary incentive (service connection status) that may be present during the CTBIE did not seem to affect Veterans' report of TBI signs.
These findings suggest that the addition of key aspects of the BAT-L approach to TBI assessment to the CTBIE could help structure clinicians' interviews and improve the latter's sensitivity to detect mTBI and reject possible exposures that did not result in mTBI. Clinicians can continue to use the CTBIE in its valid format, but they may benefit from incorporating additional probes to obtain a detailed timeline for each possible injury and evaluate functioning immediately after injury (eg, duration of acute TBI signs such as AMS, PTA, and LOC) to avoid confounding the diagnosis by considering symptoms that may have developed later because of other factors (such as long-standing nonspecific PCS). Clinicians could also be trained to use probes to discern AMS from common potential military confounds (eg, chaos secondary to combat). It may be beneficial for the CTBIE examiners to query about blast exposure (without resultant TBI) and noncombat-related mTBIs, because these injuries can impact the Veterans' current functioning. 10, 11 There were 2 primary factors at play that contributed to the disagreement between assessments. First, a great Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
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deal of the inconsistency between the 2 assessments may be attributed to human error, most likely due to the lack of clear guidelines for TBI diagnosis in the CTBIE. The CTBIE computer template now "flags" these inconsistencies, which should reduce examiner error in diagnosis. The additional clinical training described earlier may also reduce these errors. Second, incongruity was also due to inconsistent reporting by the Veterans. Reliance of TBI diagnosis on self-report of TBI signs long after an event is an inherent problem in TBI research. 12 However, even when individuals who reported inconsistent signs between the 2 assessments were removed, there were still meaningful differences between the 2 measures.
The primary limitation of this study was that both assessments of TBI referred to events that are remote, in some cases months to years before the assessment. As such, responses may have been influenced by individuals' memory of the injury. Despite this limitation, self-report via semistructured interview by trained clinicians remains the gold standard for TBI diagnosis 12 and assessment of remote TBI is commonly required in actual clinical practice. Another limitation is the inherent difficulty of diagnosing TBI remotely when it occurred in a confusing and stressful combat setting. It is possible that trauma associated with the incident injury itself, or the surrounding combat, and not a direct injury to the brain better accounts for the Veterans' AMS both at the time of the event and their recurring problems with function and self-reported symptoms.
Future research is necessary to compare the clinical outcomes of Veterans diagnosed with TBI on each of these measures to determine which measure is more accurate in identifying Veterans at risk for future functional decline. Part of our mission at TRACTS is to examine the relationships between TBI indices (as assessed by the BAT-L) as well as other co-occurring conditions and functional outcome postdeployment. Such longitudinal information will provide the necessary data needed to set clinical goals to improve service members' overall functionality. TBI does not occur in isolation; therefore, the many co-occurring conditions and their effects on function must also be considered when assessing the impact of TBI on outcome.
